rosiglitazone has been researched along with indican in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiou, TY; Chou, CA; Kuo, WH; Lee, CT; Lee, YT; Li, LC; Ng, HY; Pei, SN | 1 |
1 other study(ies) available for rosiglitazone and indican
| Article | Year |
|---|---|
Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.
Topics: Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Indican; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; NF-kappa B; Oxidative Stress; Rosiglitazone; Thiazolidinediones | 2015 |